P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited-stage classical Hodgkin lymphoma

Kim Linton

Research output: Contribution to journalMeeting Abstractpeer-review

52 Downloads (Pure)
Original languageEnglish
JournalHemaSphere
DOIs
Publication statusPublished - 2022
EventThe 12th International Symposium on Hodgkin Lymphoma: ISHL12 2022 - Cologne, Germany
Duration: 22 Oct 202224 Oct 2022

Cite this